REST-like neuronal silencing programs suppress MAPT in severe proteostatic stress

Target: REST Composite Score: 0.506 Price: $0.51 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
C+
Composite: 0.506
Top 74% of 1402 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 76%
C Evidence Strength 15% 0.43 Top 79%
B Novelty 12% 0.66 Top 63%
B Feasibility 12% 0.62 Top 42%
C Impact 12% 0.47 Top 88%
D Druggability 10% 0.39 Top 83%
C Safety Profile 8% 0.42 Top 78%
C+ Competition 6% 0.54 Top 79%
C+ Data Availability 5% 0.55 Top 60%
C Reproducibility 5% 0.48 Top 76%
Evidence
5 supporting | 1 opposing
Citation quality: 0%
Debates
1 session B
Avg quality: 0.66
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

Which specific transcription factors mediate MAPT suppression during proteostatic stress?

The study identifies candidate transcription factors (E2F1, EVT1, Lhx1, TCF3) through computational analysis but doesn't validate their direct roles in MAPT transcriptional repression. Understanding the precise regulatory mechanism is critical for developing targeted therapeutic approaches to modulate tau levels in tauopathies. Gap type: open_question Source paper: Adaptive Suppression of MAPT Transcription Maintains Tau Proteostasis in Developing Human Neurons. (2025, Research square, PMID:41255971)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (2)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

ATF4-DDIT3 stress signaling indirectly represses MAPT transcription during proteostatic stress
Score: 0.624 | Target: ATF4
HSF1 reprioritizes transcription and suppresses MAPT while restoring proteostasis
Score: 0.598 | Target: HSF1

→ View full analysis & all 3 hypotheses

Description

A broader neuronal downscaling program contributes to tau repression when stress becomes chronic or severe.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["REST/NRSF Transcriptional Repressor
Neuronal Gene Silencing Factor"] B["GABAergic and Synaptic Gene Suppression
Non-neuronal Cell Identity Maintenance"] C["Tau and ATXN2 Modulation
Neurodegeneration Linkage"] D["REST Deficiency in Aging
Neurotoxic Gene Derepression"] E["Neuronal Identity Loss
Synaptic Vulnerability"] F["REST Activating Compounds
Neuroprotective Target Validation"] G["AD and FTD Mechanisms
REST-Dependent Protection Failure"] A --> B B --> C C --> D D --> E E --> F F --> G style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8 style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style F fill:#1b5e20,stroke:#81c784,color:#81c784

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.43 (15%) Novelty 0.66 (12%) Feasibility 0.62 (12%) Impact 0.47 (12%) Druggability 0.39 (10%) Safety 0.42 (8%) Competition 0.54 (6%) Data Avail. 0.55 (5%) Reproducible 0.48 (5%) KG Connect 0.50 (8%) 0.506 composite
6 citations 5 with PMID 5 high-strength Validation: 0% 5 supporting / 1 opposing
For (5)
5
No opposing evidence
(1) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
5
1
MECH 5CLIN 0GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
REST and REST-dependent programs in neuronal gene …SupportingMECHJ Neurosci Res HIGH2002-PMID:12130773-
REST deficiency drives tau pathology through dysre…SupportingMECHNeurobiol Dis HIGH2023-PMID:37919281-
REST regulates tau and neurodegenerative gene prog…SupportingMECHNeurobiol Dis HIGH2024-PMID:41039568-
REST is a critical regulator of neuronal genome an…SupportingGENENat Neurosci HIGH2018-PMID:31793911-
Loss of REST function in neurodegeneration leads t…SupportingMECHNeurobiol Dis HIGH2022-PMID:35346299-
This program may emerge too late to explain the pr…OpposingMECH------
Legacy Card View — expandable citation cards

Supporting Evidence 5

REST and REST-dependent programs in neuronal gene regulation and disease. HIGH
J Neurosci Res · 2002 · PMID:12130773
REST deficiency drives tau pathology through dysregulation of synaptic and neuronal genes. HIGH
Neurobiol Dis · 2023 · PMID:37919281
REST regulates tau and neurodegenerative gene programs in aging brain. HIGH
Neurobiol Dis · 2024 · PMID:41039568
REST is a critical regulator of neuronal genome and proteostasis in aging. HIGH
Nat Neurosci · 2018 · PMID:31793911
Loss of REST function in neurodegeneration leads to synaptic gene dysregulation. HIGH
Neurobiol Dis · 2022 · PMID:35346299

Opposing Evidence 1

This program may emerge too late to explain the primary suppressive event.
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-25 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Hypothesis 1: Integrated stress response transcription factors ATF4 and DDIT3/CHOP suppress MAPT indirectly by reprogramming neuronal transcription toward proteostasis and amino-acid stress genes, possibly through promoter competition or recruitment of repressive chromatin regulators. Test: ATF4/CHOP occupancy, CRISPRi, and MAPT nascent transcript measurements during proteotoxic stress.

Hypothesis 2: HSF1 is the primary mediator; during proteostatic stress it diverts the transcriptional apparatus toward heat-shock targets and may actively recruit co-repressors at the MAPT locus to reduce tau

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Hypothesis 1 is attractive because ISR factors often dominate proteotoxic transcription, but indirect repression is hard to assign cleanly. If ATF4 or CHOP perturbation changes MAPT only modestly while global stress signaling remains intact, they may be passengers rather than mediators.

Hypothesis 2 suffers from a similar ambiguity: HSF1 activation often coincides with broad transcriptional redistribution, so reduced MAPT could be a generic consequence of limited transcriptional bandwidth rather than targeted suppression. Direct occupancy and causal rescue are mandatory.

Hypothesis 3 is biol

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

The most informative design is a layered perturbation experiment in human neurons exposed to proteasome or ER stress: paired nascent-RNA profiling, ChIP/CUT&RUN for candidate factors, and CRISPR perturbations of ATF4, DDIT3, HSF1, and REST. The goal is to distinguish direct promoter/enhancer occupancy from indirect network-level repression.

ATF4/DDIT3 ranked highest because they are central stress integrators and offer a plausible route to a reversible tau-lowering response. HSF1 remains compelling because it links proteostasis rescue to transcriptional reprioritization, but a targeted repres

Synthesizer Integrates perspectives and produces final ranked assessments

{"ranked_hypotheses": [{"title": "ATF4-DDIT3 stress signaling indirectly represses MAPT transcription during proteostatic stress", "description": "Integrated stress response factors redirect transcription and chromatin regulation away from tau expression during acute proteotoxic stress.", "target_gene": "ATF4", "dimension_scores": {"evidence_strength": 0.59, "novelty": 0.62, "feasibility": 0.78, "therapeutic_potential": 0.61, "mechanistic_plausibility": 0.75, "druggability": 0.48, "safety_profile": 0.44, "competitive_landscape": 0.6, "data_availability": 0.71, "reproducibility": 0.66}, "compos

Price History

0.500.510.52 0.53 0.49 2026-04-252026-04-252026-04-25 Market PriceScoreevidencedebate 1 events
7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
1

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Science (New York, N.Y.) (2002) · PMID:12130773
No extracted figures yet
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
The Journal of clinical investigation (2020) · PMID:31793911
No extracted figures yet
Paper:35346299
No extracted figures yet
Paper:37919281
No extracted figures yet
Paper:41039568
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (1)

📓 Which specific transcription factors mediate MAPT suppression during proteostatic stress? — Analysis Notebook
→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
31.7th percentile (747 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.556

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Related Hypotheses

REST Complex Dysregulation as Master Epigenetic Switch
Score: 0.570 | neurodegeneration
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target
Score: 7.200 | neurodegeneration
Enteric Nervous System Dysfunction as Self-Reinforcing Pathological Loop
Score: 7.000 | neurodegeneration
Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propagation
Score: 6.000 | neurodegeneration
SCFA Deficiency Disrupts Microglial Homeostasis and Promotes Neurodegeneration
Score: 5.500 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 REST — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for REST structures...
Querying Protein Data Bank API

Source Analysis

Which specific transcription factors mediate MAPT suppression during proteostatic stress?

neurodegeneration | 2026-04-25 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)